LKL International Bhd (XKLS:0182) Beneish M-Score: -2.72 (As of Jun. 26, 2026)


What is LKL International Bhd Beneish M-Score?

LKL International Bhd XKLS:0182 Beneish M-Score is -2.72 as of Jun. 26, 2026. The stock has 5 warning signs investors should review. Among 766 Medical Devices & Instruments companies, LKL International Bhd ranks better than 62.27% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.72 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for LKL International Bhd's Beneish M-Score or its related term are showing as below:

XKLS:0182' s Beneish M-Score Range Over the Past 10 Years
Min: -4.53   Med: -2.95   Max: 343.82
Current: -2.72

During the past 10 years, the highest Beneish M-Score of LKL International Bhd was 343.82. The lowest was -4.53. And the median was -2.95.

LKL International Bhd Beneish M-Score Historical Data

* Premium members only.

The historical data trend for LKL International Bhd's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LKL International Bhd Beneish M-Score Chart

LKL International Bhd Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Sep22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.80 343.82 -3.49 -3.19 -2.93

LKL International Bhd Quarterly Data
Oct20 Jan21 Jul21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.53 -4.39 -3.86 -2.93 -2.72

XKLS:0182 vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, LKL International Bhd's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LKL International Bhd Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where LKL International Bhd's Beneish M-Score falls into.


LKL International Bhd Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of LKL International Bhd for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6346+0.528 * 1.5465+0.404 * 1.9826+0.892 * 1.0558+0.115 * -0.0813
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0298+4.679 * -0.104426-0.327 * 1.0547
=-2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was RM9.11 Mil.
Revenue was 7.623 + 22.458 + 12.156 + 10.22 = RM52.46 Mil.
Gross Profit was 1.678 + 3.55 + 3.511 + 1.606 = RM10.35 Mil.
Total Current Assets was RM34.41 Mil.
Total Assets was RM152.19 Mil.
Property, Plant and Equipment(Net PPE) was RM63.95 Mil.
Depreciation, Depletion and Amortization(DDA) was RM14.42 Mil.
Selling, General, & Admin. Expense(SGA) was RM20.97 Mil.
Total Current Liabilities was RM32.52 Mil.
Long-Term Debt & Capital Lease Obligation was RM19.44 Mil.
Net Income was -4.331 + -17.148 + 2.157 + -9.665 = RM-28.99 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = RM0.00 Mil.
Cash Flow from Operations was 0.866 + -18.641 + -4.339 + 9.019 = RM-13.10 Mil.
 Total Receivables was RM13.60 Mil.
Revenue was 11.66 + 17.144 + 11.166 + 9.716 = RM49.69 Mil.
Gross Profit was 3.495 + 7.423 + 1.531 + 2.704 = RM15.15 Mil.
Total Current Assets was RM55.85 Mil.
Total Assets was RM187.55 Mil.
Property, Plant and Equipment(Net PPE) was RM98.25 Mil.
Depreciation, Depletion and Amortization(DDA) was RM-1.45 Mil.
Selling, General, & Admin. Expense(SGA) was RM19.29 Mil.
Total Current Liabilities was RM58.76 Mil.
Long-Term Debt & Capital Lease Obligation was RM1.95 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(9.109 / 52.457) / (13.595 / 49.686)
=0.173647 / 0.273618
=0.6346

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(15.153 / 49.686) / (10.345 / 52.457)
=0.304975 / 0.197209
=1.5465

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (34.409 + 63.95) / 152.185) / (1 - (55.845 + 98.25) / 187.554)
=0.353688 / 0.178397
=1.9826

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=52.457 / 49.686
=1.0558

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(-1.447 / (-1.447 + 98.25)) / (14.415 / (14.415 + 63.95))
=-0.014948 / 0.183947
=-0.0813

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20.974 / 52.457) / (19.292 / 49.686)
=0.399832 / 0.388278
=1.0298

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((19.436 + 32.517) / 152.185) / ((1.946 + 58.76) / 187.554)
=0.341381 / 0.323672
=1.0547

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-28.987 - 0 - -13.095) / 152.185
=-0.104426

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

LKL International Bhd has a M-score of -2.72 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.72 mean?
LKL International Bhd (XKLS:0182) has a Beneish M-Score of -2.72 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on LKL International Bhd and its competitors. According to the industry distribution chart, LKL International Bhd ranks #289 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 37.7%.
Is LKL International Bhd's Beneish M-Score too high?
LKL International Bhd's current Beneish M-Score is -2.72. Based on the distribution chart, LKL International Bhd ranks #289 out of 766 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does LKL International Bhd's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, LKL International Bhd ranks #289 out of 766 companies for Beneish M-Score. This puts LKL International Bhd in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on LKL International Bhd and its competitors. LKL International Bhd's current Beneish M-Score is -2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.04 — trading 30% below its estimated fair value. The current Beneish M-Score is -2.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current Beneish M-Score is -2.72 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LKL International Bhd Business Description

Address Wisma LKL, No.3, Jalan BS 7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, Seri Kembangan, SGR, MYS, 43300
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.